|
Volumn 40, Issue 1, 2012, Pages 301-302
|
Etomidate in critically ill Patients. Is it safe?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
ETOMIDATE;
FLUDROCORTISONE;
HYDROCORTISONE;
KETAMINE;
MIDAZOLAM;
NORADRENALIN;
PLACEBO;
ADRENAL INSUFFICIENCY;
ARTIFICIAL VENTILATION;
CRITICALLY ILL PATIENT;
DRUG EFFECT;
DRUG FATALITY;
DRUG SAFETY;
DRUG SUBSTITUTION;
EDITORIAL;
HUMAN;
INTENSIVE CARE UNIT;
INTUBATION;
LENGTH OF STAY;
MORTALITY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RESPIRATORY DISTRESS;
SCORING SYSTEM;
SEPSIS;
SEPTIC SHOCK;
SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE;
SINGLE DRUG DOSE;
TREATMENT DURATION;
TREATMENT RESPONSE;
UNSPECIFIED SIDE EFFECT;
ADRENAL INSUFFICIENCY;
ANESTHETICS, INTRAVENOUS;
CRITICAL ILLNESS;
ETOMIDATE;
FEMALE;
HUMANS;
HYDROCORTISONE;
MALE;
|
EID: 84055184193
PISSN: 00903493
EISSN: 15300293
Source Type: Journal
DOI: 10.1097/CCM.0b013e318232647f Document Type: Editorial |
Times cited : (5)
|
References (10)
|